Description

Buy Authentic CJC-1295 + GHRP-2 (10mg Blend)

CJC-1295 + GHRP-2 (10mg Blend) is a research-use-only peptide blend supplied for controlled laboratory workflows, multi-compound documentation review, and analytical characterization. This blend is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.

What CJC-1295 + GHRP-2 10mg blend is:

This is a research chemical vial combining two synthetic peptides. CJC-1295 is a long-acting analog of GHRH with a Drug Affinity Complex, DAC, that binds albumin to extend half-life. GHRP-2 is a growth hormone-releasing peptide that acts on the ghrelin receptor. A “10mg blend” usually means 5mg of each, but ratios vary by supplier. Both are sold “for research use only” and are not FDA-approved drugs.

Key Product Details of CJC-1295 + GHRP-2 (10mg Blend)

• Manufactured in accordance with rigorous quality standards to support ≥99% purity, as reflected in batch-specific documentation where available.
• Every batch is third-party analyzed for identity, assay/potency, and sterility documentation where applicable.
• Supplied in lyophilized powder form to help preserve stability throughout transport and storage.
• Produced with lot-level traceability to support research documentation and laboratory recordkeeping.
• Formulated as a multi-compound research blend containing CJC-1295 and GHRP-2, 10mg total.

Research Documentation Context

• Supports review of multi-compound blend composition in controlled laboratory settings.
• Provides batch-specific identity and purity documentation for research review.
• Allows lot-level traceability across laboratory documentation workflows.
• Supports comparison of product labeling, analytical documentation, and storage information during research planning.
• Assists researchers in evaluating individual component amounts within a clearly disclosed peptide blend.

Specifications and Documentation

• Blend Composition: CJC-1295 + GHRP-2, 10mg total.
• Certificate of Analysis: Available with batch-specific documentation where applicable.
• Material Safety Data Sheet: Coming Soon.
• Handling and Storage Instructions: Coming Soon.
• Product Form: Lyophilized powder.
• Purity Specification: ≥99% purity.
• Intended Use: Laboratory research use only.

CJC-1295 + GHRP-2 (10mg Blend) is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.

How researchers study this combo

In preclinical models, CJC-1295 is used to study sustained GHRH receptor activation and pulsatile GH release. GHRP-2 is used to study ghrelin receptor agonism, which triggers GH release and also affects appetite. Labs combine them to investigate synergistic GH pulse amplification: GHRH provides the signal, GHRP-2 sensitizes the pituitary to it. Studies use cell culture, receptor assays, and animal models of GH axis regulation.

Why the blend gets research attention

The rationale in research is pathway synergy. GHRH analogs like CJC-1295 stimulate GH, but the pituitary can become desensitized. Ghrelin receptor agonists like GHRP-2 potentiate the GHRH signal and help maintain pulse amplitude. Researchers use the combo to model physiologic vs pharmacologic GH secretion patterns. Neither compound has human efficacy/safety data outside small, unreplicated trials.

Form, purity & handling

The blend comes as a white lyophilized powder in a sealed sterile vial. Reputable suppliers provide a COA with HPLC and mass spec for both peptides, usually >95% purity each. Both are sensitive to heat, light, and moisture. The DAC on CJC-1295 makes it more stable, but GHRP-2 is still fragile. Ship cold, store at -20°C or -80°C after reconstitution. Pharmaceutical-grade versions don’t exist.

Legal + safety status

Neither CJC-1295 nor GHRP-2 is FDA-approved for any medical use. Sermorelin, a short-acting GHRH analog, was previously approved but discontinued by the manufacturer. The blend is “for research use only, not for human consumption.” No established human dosing, no long-term safety data, no clinical trials meeting FDA standards. Both are banned by WADA for athletes. GH axis manipulation carries risks: edema, insulin resistance, tumor growth promotion in theory.

Bottom line

: *CJC-1295 + GHRP-2 10mg blend* is a research tool used to study GHRH + ghrelin receptor synergy in GH regulation in the lab. While GH deficiency is a real medical condition, it’s diagnosed with stimulation tests and treated with FDA-approved recombinant GH under endocrinologist care. This blend has no regulatory approval, clinical efficacy data, or human safety profile. For hormone, aging, or body composition concerns, talk to a licensed healthcare provider about evidence-based testing and treatments.